Search results
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 12 hours agoThousands of lawsuits began piling up in federal and state courts against Pfizer, GSK, Sanofi and...
GSK expands collaboration with BioVersys on tuberculosis asset alpibectir
Seeking Alpha· 1 day agoGSK expands collaboration with BioVersys AG and invests in their latest funding round, propelling...
Earnings call: GSK forecasts growth with strong Q1 performance By Investing.com
Investing.com· 5 days agoGSK upgraded its full-year guidance, expecting another year of substantial growth for shareholders,...
Here's Why GSK (GSK) is a Strong Value Stock
Zacks via Yahoo Finance· 15 hours agoUtilizing ratios like P/E, PEG, Price/Sales, and Price/Cash Flow, the Value Style Score identifies the most attractive and most discounted stocks. GSK (...
GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St. via Yahoo Finance· 7 days agoGSK (LON:GSK) First Quarter 2024 Results Key Financial Results Revenue: UK£7.36b (up 5.9% from 1Q...
GSK plc (NYSE:GSK) Given Average Rating of “Hold” by Analysts
ETF DAILY NEWS· 2 days agoShares of GSK plc (NYSE:GSK – Get Free Report) have been assigned a consensus recommendation of “Hold” from the five analysts that are presently covering ...
Pfizer Agrees to Settle More Than 10,000 Zantac Cancer Lawsuits
Insurance Journal· 13 hours agoThe deal is likely to reassure investors, who have seen other Zantac makers, including GSK Plc and...
BioVersys and GSK expand their partnership for TB treatment alpibectir
Pharmaceutical Technology via Yahoo Finance· 20 hours agoBioVersys and GSK have announced the expansion of their strategic partnership to expedite the...
GSK Stock Today: Buying An August Covered Call Boosts Your Return By This Much
Investor's Business Daily· 2 days agoA covered call strategy is one way to slightly reduce the risk on a long stock position while also...
Atria Wealth Solutions Inc. Boosts Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 7 days agoAtria Wealth Solutions Inc. lifted its stake in GSK plc (NYSE:GSK – Free Report) by 13.2% in the 4th quarter, according to the company in its most recent ...